bromodeoxyuridine has been researched along with d 609 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dempsey, RJ; Kalluri, HS | 1 |
| Adibhatla, RM; Dempsey, RJ; Gusain, A; Hatcher, JF; Wesley, UV | 1 |
| Bi, J; Gao, J; Miao, J; Shao, J; Su, L; Sun, C; Yang, S; Zhang, S; Zhao, J | 1 |
3 other study(ies) available for bromodeoxyuridine and d 609
| Article | Year |
|---|---|
D609 inhibits the proliferation of neural progenitor cells.
Topics: Adult Stem Cells; Animals; Bridged-Ring Compounds; Bromodeoxyuridine; Cell Count; Cell Death; Cell Proliferation; Cells, Cultured; Cyclin D1; Immunoblotting; Neurogenesis; Neurons; Norbornanes; Phosphodiesterase Inhibitors; Phosphorylation; Rats; Rats, Inbred SHR; Retinoblastoma Protein; Thiocarbamates; Thiones; Type C Phospholipases | 2010 |
Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.
Topics: Animals; Bridged-Ring Compounds; Bromodeoxyuridine; Caspase 3; Cell Cycle; Cell Cycle Checkpoints; Cell Line; Cell Proliferation; Cell Survival; Ceramides; Cyclin-Dependent Kinase Inhibitor p21; Diglycerides; Dose-Response Relationship, Drug; Enzyme Activation; Mice; Norbornanes; Sphingomyelins; Thiocarbamates; Thiones; Time Factors | 2012 |
Cholinergic neuron-like cells derived from bone marrow stromal cells induced by tricyclodecane-9-yl-xanthogenate promote functional recovery and neural protection after spinal cord injury.
Topics: Acetylcholine; Animals; Axons; Biomarkers; Bridged-Ring Compounds; Bromodeoxyuridine; Cell Differentiation; Choline O-Acetyltransferase; Cholinergic Neurons; Glutamate Decarboxylase; Graft Rejection; Immunohistochemistry; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Motor Neurons; Nerve Regeneration; Neuroprotective Agents; Norbornanes; Rats; Recovery of Function; Spinal Cord Injuries; Thiocarbamates; Thiones; Transplantation, Heterologous | 2013 |